LEVO ALPHA ACETYLMETHADOL (LAAM) VERSUS METHADONE MAINTENANCE: 1 YEAR TREATMENT RETENTION, OUTCOMES AND STATUS
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Journal Article |
| Language: | English |
| Subjects: | |
| Online Access: | Path |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: LEVO ALPHA ACETYLMETHADOL (LAAM) VERSUS METHADONE MAINTENANCE: 1 YEAR TREATMENT RETENTION, OUTCOMES AND STATUS
- LEVO-ALPHA-ACETYLMETHADOL (LAAM) VERSUS METHADONE: TREATMENT RETENTION AND OPIATE USE
- THE USE OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) IN METHADONE PATIENTS WHO HAVE NOT ACHIEVED HEROIN ABSTINENCE
- AN ASSESSMENT OF THE POTENTIAL CROSS-REACTIVITY OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) WITH URINE ASSAYS FOR METHADONE
- A RANDOMIZED TRIAL COMPARING LEVO-ALPHA ACETYLMETHADOL WITH METHADONE MAINTENANCE FOR PATIENTS IN PRIMARY CARE SETTING IN AUSTRALIA
- LEVO-ALPHA-ACETYLMETHADOL (LAAM): CLINICAL, RESEARCH, AND POLICY ISSUES OF A NEW PHARMACOTHERAPY FOR OPIOID ADDICTION
- LEVO-ALPHA ACETYL METHADOL (LAAM). ITS ADVANTAGES AND DRAWBACKS